13th World BiSpecific Summit – Boston

–

Get the Latest to Your Inbox

First Name(Required)

Last Name(Required)

Email(Required)

CAPTCHA

Latest News

09.07.22

Ernst and Young Selects Josh Eckman, CEO of Carterra, as 2022 Entrepreneur of the Year Mountain West Award Winner

08.01.22

University of Manchester Adds Carterra’s LSA Instrument for High-Throughput Antibody Screening and Characterization

Resources

Poster

Use of High Throughput SPR to Characterize Antibodies To Common Cancer Biomarkers

Poster

Characterizing Challenging Membrane Targets Using HT-SPR

Presentations

Presentation: High throughput SPR characterization of multi-specific antibodies – New Capabilities and workflow presented at the World BiSpecifics Summit

Peer-Reviewed Publication

Science: Broadly neutralizing antibodies target the coronavirus fusion peptide

Peer-Reviewed Publication

Cell Reports: LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

825 N. 300 W. Ste. C309
Salt Lake City, UT 84103

Ph: (844) 642-7635
questions@carterra-bio.com

Carterra LSA
Technology
About Us
News
Events
Resources
Blog
Contact

Applications

Kinetics Software
Epitope Analysis Software for Protein-Protein Interactions
Advanced SPR Platform for High Throughput Kinetics Screening
Epitope Binning
Quantitation
DNA Encoded Libraries (DEL)
Antibody Epitope Mapping
Therapeutic Areas
Antibody Discovery & Other Therapeutic Formats

Privacy Policy

Website by Metropolis Creative